• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A preventable cancer.

作者信息

Laursen Lucas

出版信息

Nature. 2014 Dec 4;516(7529):S2-3. doi: 10.1038/516S2a.

DOI:10.1038/516S2a
PMID:25470197
Abstract
摘要

相似文献

1
A preventable cancer.一种可预防的癌症。
Nature. 2014 Dec 4;516(7529):S2-3. doi: 10.1038/516S2a.
2
Screening for hepatocellular carcinoma: from lack of evidence to common sense.
Hepatology. 2010 Nov;52(5):1863-4. doi: 10.1002/hep.23780.
3
Curbing the liver cancer epidemic in Africa.遏制非洲的肝癌流行趋势。
Lancet. 2008 Feb 2;371(9610):367-8. doi: 10.1016/S0140-6736(08)60181-6.
4
Liver cancer epidemic in China: past, present and future.中国肝癌流行态势：过去、现在和未来。
Semin Cancer Biol. 2011 Feb;21(1):59-69. doi: 10.1016/j.semcancer.2010.11.002. Epub 2010 Dec 7.
5
[Liver cancer in the Chinese].
Dtsch Med Wochenschr. 1979 Jun 29;104(26):949-54. doi: 10.1055/s-0028-1104022.
6
[The epidemiology, risk factors and prevention of liver cancer].
Gastroenterol Hepatol. 1997 May;20(5):248-58.
7
[Statistical review of primary liver cancer].
Nihon Rinsho. 1993 Jan;51 Suppl:727-34.
8
Hepatocarcinoma in viral and metabolic liver disease.病毒性和代谢性肝病中的肝癌
J Pediatr Gastroenterol Nutr. 2008 Apr;46(4):370-5. doi: 10.1097/MPG.0b013e318158799b.
9
Coffee, liver enzymes, cirrhosis and liver cancer.咖啡、肝酶、肝硬化与肝癌
J Hepatol. 2005 Apr;42(4):444-6. doi: 10.1016/j.jhep.2005.01.004. Epub 2005 Jan 21.
10
Preventing infection-associated cancer: from bench to hillside.预防感染相关癌症：从实验室到临床实践
J Natl Cancer Inst. 2005 Feb 16;97(4):245-6. doi: 10.1093/jnci/dji059.

引用本文的文献

1
A Pair of Fluorescent Probes Enabling Precise Diagnosis of Liver Cancer by Complementary Imaging.一对通过互补成像实现肝癌精准诊断的荧光探针。
ACS Cent Sci. 2024 Dec 16;11(1):76-83. doi: 10.1021/acscentsci.4c01822. eCollection 2025 Jan 22.
2
Pinpointing the integration of artificial intelligence in liver cancer immune microenvironment.精准定位人工智能在肝癌免疫微环境中的整合情况。
Front Immunol. 2024 Dec 20;15:1520398. doi: 10.3389/fimmu.2024.1520398. eCollection 2024.
3
Overexpression of Aurora Kinase B Is Correlated with Diagnosis and Poor Prognosis in Hepatocellular Carcinoma.

本文引用的文献

1
Emerging trends in hepatocellular carcinoma incidence and mortality.肝细胞癌发病率和死亡率的新趋势。
Hepatology. 2015 Jan;61(1):191-9. doi: 10.1002/hep.27388. Epub 2014 Nov 24.
2
Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program.婴儿接种乙肝疫苗对冈比亚乙型肝炎干预研究（1986-1990 年）和全国免疫规划的疗效和效果。
BMC Infect Dis. 2014 Jan 7;14:7. doi: 10.1186/1471-2334-14-7.
3
The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis.
Aurora 激酶 B 的过表达与肝细胞癌的诊断和不良预后相关。
Int J Mol Sci. 2024 Feb 12;25(4):2199. doi: 10.3390/ijms25042199.
4
Dual-phenotype hepatocellular carcinoma: correlation of MRI features with other primary hepatocellular carcinoma and differential diagnosis.双表型肝细胞癌：MRI特征与其他原发性肝细胞癌的相关性及鉴别诊断
Front Oncol. 2024 Jan 11;13:1253873. doi: 10.3389/fonc.2023.1253873. eCollection 2023.
5
Tumor purity-associated genes influence hepatocellular carcinoma prognosis and tumor microenvironment.肿瘤纯度相关基因影响肝细胞癌的预后和肿瘤微环境。
Front Oncol. 2023 Jun 26;13:1197898. doi: 10.3389/fonc.2023.1197898. eCollection 2023.
6
Comprehensive analysis of candidate signatures of long non-coding RNA LINC01116 and related protein-coding genes in patients with hepatocellular carcinoma.肝细胞癌患者长链非编码 RNA LINC01116 及其相关蛋白编码基因的候选特征综合分析。
BMC Gastroenterol. 2023 Jun 20;23(1):216. doi: 10.1186/s12876-023-02827-y.
7
Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma.乙型肝炎病毒相关性肝细胞癌的外周免疫特征。
Front Immunol. 2023 Apr 3;14:1079495. doi: 10.3389/fimmu.2023.1079495. eCollection 2023.
8
JIB-04, a Pan-Inhibitor of Histone Demethylases, Targets Histone-Lysine-Demethylase-Dependent AKT Pathway, Leading to Cell Cycle Arrest and Inhibition of Cancer Stem-Like Cell Properties in Hepatocellular Carcinoma Cells.JIB-04，一种组蛋白去甲基化酶的泛抑制剂，靶向组蛋白赖氨酸去甲基化酶依赖性 AKT 通路，导致肝癌细胞周期停滞和抑制癌症干细胞样细胞特性。
Int J Mol Sci. 2022 Jul 11;23(14):7657. doi: 10.3390/ijms23147657.
9
Long Noncoding RNA LINC00467: Role in Various Human Cancers.长链非编码RNA LINC00467：在多种人类癌症中的作用
Front Genet. 2022 Jun 1;13:892009. doi: 10.3389/fgene.2022.892009. eCollection 2022.
10
Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignancies.血浆游离RNA分析可区分实体瘤和血液系统恶性肿瘤中的癌症与癌前病变。
NPJ Precis Oncol. 2022 Apr 25;6(1):28. doi: 10.1038/s41698-022-00270-y.
埃及丙型肝炎病毒的流行病学：系统评价和数据综合。
BMC Infect Dis. 2013 Jun 24;13:288. doi: 10.1186/1471-2334-13-288.
4
Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies.超重与原发性肝癌风险：前瞻性研究的更新荟萃分析。
Eur J Cancer. 2012 Sep;48(14):2137-45. doi: 10.1016/j.ejca.2012.02.063. Epub 2012 Mar 23.
5
Epidemiology of primary and secondary liver cancers.原发性和继发性肝癌的流行病学
Semin Intervent Radiol. 2006 Mar;23(1):47-63. doi: 10.1055/s-2006-939841.
6
Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.黄曲霉毒素诱发肝细胞癌的全球负担：一项风险评估。
Environ Health Perspect. 2010 Jun;118(6):818-24. doi: 10.1289/ehp.0901388. Epub 2010 Feb 19.
7
National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.1998 - 2003年肝细胞癌发病率的全国趋势及差异
Prev Chronic Dis. 2008 Jul;5(3):A74. Epub 2008 Jun 15.
8
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies.超重、肥胖与肝癌风险：队列研究的荟萃分析
Br J Cancer. 2007 Oct 8;97(7):1005-8. doi: 10.1038/sj.bjc.6603932. Epub 2007 Aug 14.
9
Population-attributable risk of dietary aflatoxins and hepatitis B virus infection with respect to hepatocellular carcinoma.膳食黄曲霉毒素和乙型肝炎病毒感染对肝细胞癌的人群归因风险。
Nutr Cancer. 2004;48(1):15-21. doi: 10.1207/s15327914nc4801_3.
10
Cancer control in Thailand.
Jpn J Clin Oncol. 2002 Mar;32 Suppl:S82-91. doi: 10.1093/jjco/hye134.